Pathophysiological role and potential drug target of NLRP3 inflammasome in the metabolic disorders
Authors:
Open Access
- 26 July 2024
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 122, 111320
Abstract
No abstract availableKeywords
Funding Information
- Jiangxi Provincial Natural Science Foundation (20212BAB206013)
- Jiangxi Provincial Department of Science and Technology (GJJ2203502)
- Education Department of Jiangxi Province
- National Natural Science Foundation of China (82260794)
- China Scholarship Council (202008360253)
This publication has 120 references indexed in Scilit:
- miR-155 activates the NLRP3 inflammasome by regulating the MEK/ERK/NF-κB pathway in carotid atherosclerotic plaques in ApoE−/− miceJournal of Physiology and Biochemistry, 2022
- Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cellsEuropean Journal of Nutrition, 2022
- Interactions between NLRP3 inflammasome and glycolysis in macrophages: New insights into chronic inflammation pathogenesisImmunity, Inflammation and Disease, 2021
- Quercetin and metabolic syndrome: A reviewPhytotherapy Research, 2021
- Quercetin Attenuates Atherosclerotic Inflammation by Inhibiting Galectin‐3‐NLRP3 Signaling PathwayMolecular Nutrition & Food Research, 2021
- Chlorogenic Acid Suppresses miR‐155 and Ameliorates Ulcerative Colitis through the NF‐κB/NLRP3 Inflammasome PathwayMolecular Nutrition & Food Research, 2020
- Oxidative stress and diabetes: antioxidative strategiesFrontiers of Medicine, 2020
- NLRP3 inflammasome, an immune‐inflammatory target in pathogenesis and treatment of cardiovascular diseasesClinical and Translational Medicine, 2020
- Role and mechanism of ROS scavengers in alleviating NLRP3‐mediated inflammationBiotechnology and Applied Biochemistry, 2018
- Nrf2 signaling pathway: Pivotal roles in inflammationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2017